Vanguard Group’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1M | Buy |
|
|||||
|
2025
Q1 | $24.1M | Buy |
|
|||||
|
2024
Q4 | $14.5M | Buy |
|
|||||
|
2024
Q3 | $10.9M | Buy |
|
|||||
|
2024
Q2 | $7.26M | Buy |
|
|||||
|
2024
Q1 | $7.95M | Buy |
|
|||||
|
2023
Q4 | $3.01M | Buy |
|
|||||
|
2023
Q3 | $4.27M | Buy |
|
|||||
|
2023
Q2 | $4.57M | Buy |
|
|||||
|
2023
Q1 | $2.77M | Buy |
|
|||||
|
2022
Q4 | $2.78M | Buy |
|
|||||
|
2022
Q3 | $2.04M | Buy |
|
|||||
|
2022
Q2 | $666K | Buy |
|
|||||
|
2022
Q1 | $336K | Buy |
|
|||||
|
2021
Q4 | $111K | Buy |
|
|||||
|
2021
Q3 | $192K | Buy |
|
|||||
|
2021
Q2 | $300K | Hold |
|
|||||
|
2021
Q1 | $361K | Hold |
|
|||||
|
2020
Q4 | $322K | Hold |
|
|||||
|
2020
Q3 | $537K | Sell |
|
|||||
|
2020
Q2 | $914K | Sell |
|
|||||
|
2020
Q1 | $495K | Hold |
|
|||||
|
2019
Q4 | $564K | Hold |
|
|||||
|
2019
Q3 | $677K | Buy |
|
|||||
|
2019
Q2 | $886K | Buy |
|